ā˜°

Deborah R Kaye, MD, MS

Affiliations: 
2009-2010 National Cancer Institute, Rockville, MD, United States 
 2018- Urology Duke University Medical School, Durham, NC, United States 
Google:
"Deborah Kaye"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Moses KA, Sprenkle PC, Bahler C, et al. (2023) NCCN GuidelinesĀ® Insights: Prostate Cancer Early Detection, Version 1.2023. Journal of the National Comprehensive Cancer Network : Jnccn. 21: 236-246
Kaye DR, Lee HJ, Gordee A, et al. (2023) Medication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate Cancer. Jco Oncology Practice. OP2200645
Wilcox Vanden Berg RN, George AK, Kaye DR. (2022) Should Transperineal Prostate Biopsy Be the Standard of Care? Current Urology Reports
Sessine MS, Das S, Park B, et al. (2021) Initial Findings from a High Genetic Risk Prostate Cancer Clinic. Urology
Ginsburg KB, Jacobs JC, Qi J, et al. (2020) Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance. Urology
Ginsburg KB, Arcot R, Qi J, et al. (2019) Confirmatory MRI With or Without Biopsy Impacts Decision-Making in Newly Diagnosed Favorable Risk Prostate Cancer. The Journal of Urology
Kaye D, Zhu Z, Ellimoottil C, et al. (2019) Pd58-07 Health System Characteristics And The Quality Of Urological Cancer Care At The End Of Life The Journal of Urology. 201
Arcot R, Ginsburg K, Qi J, et al. (2019) Pd55-07 Mri With Or Without Biopsy As A Confirmatory Test In Newly Diagnosed Favorable Risk Prostate Cancer Aids In Decision-Making The Journal of Urology. 201
Herrel L, Zhu Z, Kaye D, et al. (2019) Mp44-08 Quality Of Urological Cancer Care At The End Of Life For Dual Eligible Beneficiaries And The Impact Of Delivery System Integration The Journal of Urology. 201
Hu JC, Tosoian JJ, Qi J, et al. (2018) Clinical Utility of Gene Expression Classifiers in Men With Newly Diagnosed Prostate Cancer. Jco Precision Oncology. 2
See more...